» Articles » PMID: 8589652

Bromopyruvate for the Affinity Labelling of a Single Cysteine Residue Near the Carboxylate Binding Site of Lamb Liver 6-phosphogluconate Dehydrogenase

Overview
Date 1995 Nov 1
PMID 8589652
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Bromopyruvate inactivates 6-phosphogluconate dehydrogenase by affinity labeling. Kinetic analyses, stoichiometry and isolation of a single labelled tryptic peptide of the modified protein indicate that inactivation is due to the affinity labeling of a single cysteine residue, identified as cysteine 401. It thus appears that this cysteine is within a short distance from the protein site involved in the binding of the carboxylate group of the substrate. These results suggest that the carboxylate binding site of proteins could be used as an anchorage point for affinity labeling, and that bromopyruvate can be used to individuate an amino acid residue within few A from this site.

Citing Articles

Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate.

Yadav S, Pandey S, Goel Y, Temre M, Singh S Front Pharmacol. 2019; 10:728.

PMID: 31333455 PMC: 6620530. DOI: 10.3389/fphar.2019.00728.


Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death.

Ganapathy-Kanniappan S, Geschwind J, Kunjithapatham R, Buijs M, Vossen J, Tchernyshyov I Anticancer Res. 2010; 29(12):4909-18.

PMID: 20044597 PMC: 3743725.